HCA Healthcare Options Signal 6.3% Move Ahead of July 24 Earnings

By EC Assets · Published 17 July 2026

HCA Healthcare options indicate a potential 6.3% price movement in connection with its upcoming earnings report. The company is scheduled to release its earnings on July 24. HCA Healthcare stock has experienced a recent decline in the short term. However, the stock shows a 52.3% return over the past five years. Analysts at Barclays maintain an Equal, Weight rating on HCA Healthcare and lowered their price target from $427 to $402. RBC Capital also maintains an Outperform rating but reduced its price target from $534 to $435. In the broader healthcare sector, GE HealthCare Technologies is engaged in a research collaboration with Mayo Clinic on the MI, BET theranostics trial for advanced prostate cancer. GE HealthCare Technologies has seen its share price fall 13.66% over the past 90 days. The company's one, year total shareholder return has declined 16.09%. Intuitive Surgical's stock dropped 11% despite beating Q2 estimates. The company issued a warning that insurance changes could slow U.S. procedure growth. Elevance Health, an S&P 500 managed care stock, reported Q2 earnings that topped estimates, but its medical membership declined. Profit was boosted by one, time "below, the, line" factors, and the full, year outlook was underwhelming. Elevance Health (ELV) stock tumbled following the report. Molina Healthcare also joined Elevance among the biggest laggards in pre, market trading. CareDx (CDNA) saw its share price jump in a recent session with above, average trading volume. Upcoming earnings reports and associated forward guidance will continue to be a focus for investors in the healthcare sector. This article is intended for informational purposes only. It does not constitute investment advice.